Animalcare is encouraging veterinary practices to try Daxocox, its new weekly NSAID for the management of OA pain, with an offer of £250 worth of the product completely free of charge.

To claim the free product, visit www.daxocox.co.uk/trial and use the stock selector to pick the dose sizes to suit the patients you think Daxocox could help. 

Animalcare Marketing Manager James Beaumont explained: “When you consider that recent data shows that up to 20% of dogs over one year of age could have some form of OA1, the scale of problem becomes clear – as does the threat to the welfare of our canine companions from OA pain.

“Owners already giving Daxocox to their OA-affected pets, have seen first-hand how it can significantly improve their quality of life.

"90% said that their dog’s osteoarthritis improved, with 84% reporting that their dog’s quality of life improved from “poor or fair” to “good, very good or excellent.”2

James added: “In a study carried out by Animalare, 88% of owners said that weekly NSAID dosing would be easier to remember, or mean they were less likely to miss a dose or that it would control their dog’s pain more effectively.3

“Used as a first line treatment for OA, Daxocox can provide a solid foundation to long-term pain management that suits vets, dogs and their owners.

"As such, we’re confident that once practices have tried it, it will become their canine OA NSAID of choice.”

For more information, visit www.daxocox.co.uk

References

  1. Anderson K. L., Zulch H., O’Neill D.G., Meeson R. L., Collins L.M. (2020) Risk Factors for Canine Osteoarthritis and Its Predisposing Arthropathies: A Systematic Review. Front Vet Sci. 7: 220.
  2. Internal report: DA/197/C, pending publication
  3. Daxocox® Pet Owner Insight Executive Summary (N=200) January 2021.

PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.